{"id":4190,"date":"2025-03-31T18:12:00","date_gmt":"2025-03-31T18:12:00","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/meropenem-txt\/"},"modified":"2025-03-31T18:12:00","modified_gmt":"2025-03-31T18:12:00","slug":"meropenem-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/meropenem-txt\/","title":{"rendered":"Meropenem.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3><br \/>\nAntibacterial agent<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>500 mg \u2013 1 g every 8 hoursHigher doses used in cystic fibrosis and meningitis (up to 2 g every 8 hours)<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :437.5<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :2<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 70<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :0.351<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :1\/6\u201313.72<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4><LI> 20 to 50  &amp;nbsp &amp;nbsp : 500 mg \u2013 2 g every 12 hours<LI> 10 to 20  &amp;nbsp &amp;nbsp : 500 mg \u2013 1 g every 12 hours or 500 mg every 8 hours<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 500 mg \u2013 1 g every 24 hours<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/min<\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/min or 1\u20132 g post dialysis2<LI>HDF\/high flux  &amp;nbsp :Dialysed. Dose as in GFR<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/min<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Dialysed. 0.5\u20131 g every 8 hours2,3 or 1 g every 12 hours1 CVVhdF1 g every 12 hours3<H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugsProbenecid: avoid concomitant use <H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>Add 5 mL water for injection to each  250 mg of meropenem<H4>  Route  <\/H4>IV <H4>  Rate of Administration  <\/H4>Bolus: 5 minutes IV Infusion: 15\u201330 minutes <H4>Comments<\/H4>Further dilute in 50\u2013200 mL sodium  chloride 0.9%, glucose 5% or glucose 10% if for infusionStable for 24 hours once reconstituted Minimum volume 1 g in 10 mL. (UK  Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3 rd Edition, 2006)<H4>  OTHER INFORMATION  <\/H4>Metabolite is inactive and renally excreted Each 1 g vial contains 3.9 mmol of sodium Has less potential to induce seizures than  imipenemHas been used intraperitoneally for  peritoneal dialysis Pseudomonas peritonitis at concentration of 100 mg\/L50% is removed by CVVHF, 13\u201353% by  CVVHDF, 50% by intermittent\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :.2Differences in renal replacement doses are  due to the different flow rates used in the studies<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Antibacterial agent DOSE IN NORMAL RENAL FUNCTION 500<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4190","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4190"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4190\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}